IMI PLC/S (IMIAY) Downgraded to Sell at Zacks Investment Research

Share on StockTwits

Zacks Investment Research lowered shares of IMI PLC/S (OTCMKTS:IMIAY) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning.

According to Zacks, “IMI PLC is an engineering company. It provides designs, manufactures and services for engineered products which control the movement of fluids. The company primarily serves energy, transportation and infrastructure sector. IMI PLC is headquartered in Birmingham, the United Kingdom. “

Several other equities research analysts have also recently commented on the stock. Credit Suisse Group cut shares of IMI PLC/S from a neutral rating to an underperform rating in a research report on Friday, December 7th. Royal Bank of Canada initiated coverage on shares of IMI PLC/S in a research report on Tuesday, November 20th. They issued a sector perform rating for the company. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company’s stock. IMI PLC/S has an average rating of Hold.

Shares of IMI PLC/S stock opened at $31.48 on Wednesday. IMI PLC/S has a 52 week low of $22.34 and a 52 week high of $33.15.

Featured Article: Debt-To-Equity Ratio

Get a free copy of the Zacks research report on IMI PLC/S (IMIAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for IMI PLC/S (OTCMKTS:IMIAY)

Receive News & Ratings for IMI PLC/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMI PLC/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

East West Bancorp  Shares Gap Down  Following Weak Earnings
East West Bancorp Shares Gap Down Following Weak Earnings
United Rentals  Stock Price Up 8.1% Following Strong Earnings
United Rentals Stock Price Up 8.1% Following Strong Earnings
Zacks: Analysts Expect Lexicon Pharmaceuticals, Inc.  Will Announce Quarterly Sales of $13.37 Million
Zacks: Analysts Expect Lexicon Pharmaceuticals, Inc. Will Announce Quarterly Sales of $13.37 Million
Analyzing Schlumberger  and Energy & Technology
Analyzing Schlumberger and Energy & Technology
United Traders Token Trading 16.9% Higher  This Week
United Traders Token Trading 16.9% Higher This Week
Delphy Achieves Market Cap of $4.26 Million
Delphy Achieves Market Cap of $4.26 Million


 
© 2006-2019 Zolmax.